Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-12-000010)

Filing Details

Accession Number:: 0000711377-12-000010
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-08 20:40:59
Reporting Period:: 2012-08-07

Filing Date:: 2012-08-08
Accepted Time:: 2012-08-08 20:40:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188987	A Terri Morrical		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-07	6,100	$13.55	21,788	No	4	M	Direct
Common Stock	Disposition	2012-08-07	6,100	$40.57	15,688	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right-to-Buy)	Disposition	2012-08-07	6,100	$0.00	6,100	$13.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
68,242		2012-08-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,788	Indirect	See footnote

Footnotes

Options were granted on 8/9/2007, vested 20% annually, and expire on 8/9/2012
Shares are held in the Neogen 401-k Savings Plan